![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 9/00 | (2006.01) |
A61K 47/02 | (2006.01) | ||
A61K 47/12 | (2006.01) | ||
A61K 47/26 | (2006.01) | ||
A61K 9/08 | (2006.01) | ||
A61K 9/19 | (2006.01) | ||
A61K 31/5377 | (2006.01) | ||
A61P 35/00 | (2006.01) |
(11) | Number of the document | 3233054 |
(13) | Kind of document | T |
(96) | European patent application number | 15813578.0 |
Date of filing the European patent application | 2015-12-10 | |
(97) | Date of publication of the European application | 2017-10-25 |
(45) | Date of publication and mention of the grant of the patent | 2021-06-30 |
(46) | Date of publication of the claims translation | 2021-07-26 |
(86) | Number | PCT/IB2015/059515 |
Date | 2015-12-10 |
(87) | Number | WO 2016/097949 |
Date | 2016-06-23 |
(30) | Number | Date | Country code |
201462093060 P | 2014-12-17 | US | |
201562250633 P | 2015-11-04 | US |
(72) |
BACK, Kevin Richard , GB
CRAM, Michael , GB
HARPER, Aidan James , GB
HUANG, W. James , US
LILLIS, Jonathan Richard , GB
LUKAS, Timothy Michael , GB
LUTHRA, Sumit , US
|
(73) |
Pfizer Inc. ,
235 East 42nd Street, New York, NY 10017,
US
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | PI3K/mTOR inhibitoriaus vaisto formos, skirtos intraveniniam įvedimui |
FORMULATIONS OF A PI3K/MTOR-INHIBITOR FOR INTRAVENOUS ADMINISTRATION |
Payment date | Validity (years) | Amount | |
2024-11-19 | 10 | 231.00 EUR |
2025-12-10 |